|
|
|
Insider
Information: |
Chang David D |
Relationship: |
|
City: |
Santa Monica |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
4,810,106 |
|
Indirect Shares
|
2,913,196 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
7,723,302 |
|
|
Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Kite Pharma, Inc. |
KITE |
EVP, R&D, Chief Medica... |
2017-10-03 |
0 |
2014-06-25 |
0 |
Premium* |
|
Allogene Therapeutics, Inc. |
ALLO |
|
2024-05-16 |
4,810,106 |
2024-05-16 |
2,913,196 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
64 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
KITE |
Kite Pharma, Inc. |
EVP, R&D, Chief Medical Off. |
|
2017-05-01 |
4 |
OE |
$6.89 |
$137,800 |
D/D |
20,000 |
70,165 |
0 |
- |
|
KITE |
Kite Pharma, Inc. |
EVP, R&D, Chief Medical Off. |
|
2017-09-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
375 |
57,048 |
0 |
- |
|
KITE |
Kite Pharma, Inc. |
EVP, R&D, Chief Medical Off. |
|
2017-09-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,041 |
56,007 |
0 |
- |
|
KITE |
Kite Pharma, Inc. |
EVP, R&D, Chief Medical Off. |
|
2017-09-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
157 |
55,850 |
0 |
- |
|
KITE |
Kite Pharma, Inc. |
EVP, R&D, Chief Medical Off. |
|
2017-09-20 |
4 |
GD |
$0.00 |
$0 |
D/D |
570 |
55,280 |
0 |
- |
|
KITE |
Kite Pharma, Inc. |
EVP, R&D, Chief Medical Off. |
|
2017-09-25 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
65,350 |
0 |
- |
|
KITE |
Kite Pharma, Inc. |
EVP, R&D, Chief Medical Off. |
|
2017-09-25 |
4 |
S |
$179.66 |
$1,424,196 |
D/D |
(7,927) |
57,423 |
0 |
- |
|
KITE |
Kite Pharma, Inc. |
EVP, R&D, Chief Medical Off. |
|
2017-10-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(38,675) |
0 |
0 |
- |
|
KITE |
Kite Pharma, Inc. |
EVP, R&D, Chief Medical Off. |
|
2017-10-03 |
4 |
D |
$180.00 |
$2,988,900 |
D/D |
(16,605) |
38,675 |
0 |
- |
|
ALLO |
Allogene Therapeutics, In... |
President and CEO |
|
2018-10-15 |
4 |
B |
$18.00 |
$720,000 |
D/D |
40,000 |
1,995,625 |
2.81 |
- |
|
ALLO |
Allogene Therapeutics, In... |
President and CEO |
|
2018-10-15 |
4 |
A |
$0.00 |
$0 |
I/I |
29,946 |
1,101,838 |
0 |
- |
|
ALLO |
Allogene Therapeutics, In... |
President and CEO |
|
2019-03-13 |
4 |
A |
$0.00 |
$0 |
D/D |
173,000 |
2,168,625 |
0 |
- |
|
ALLO |
Allogene Therapeutics, In... |
President and CEO |
|
2019-04-26 |
4 |
A |
$0.00 |
$0 |
I/I |
11,753 |
1,113,591 |
0 |
- |
|
ALLO |
Allogene Therapeutics, In... |
President and CEO |
|
2019-06-18 |
4 |
A |
$0.00 |
$0 |
I/I |
10,154 |
1,135,498 |
0 |
- |
|
ALLO |
Allogene Therapeutics, In... |
President and CEO |
|
2019-07-10 |
4 |
A |
$0.00 |
$0 |
D/D |
6,388 |
2,176,687 |
0 |
- |
|
ALLO |
Allogene Therapeutics, In... |
President and CEO |
|
2019-07-18 |
4 |
A |
$0.00 |
$0 |
I/I |
9,402 |
1,144,900 |
0 |
- |
|
ALLO |
Allogene Therapeutics, In... |
President and CEO |
|
2019-07-18 |
4 |
A |
$0.00 |
$0 |
D/D |
9,391 |
2,186,078 |
0 |
- |
|
ALLO |
Allogene Therapeutics, In... |
President and CEO |
|
2019-09-05 |
4 |
A |
$0.00 |
$0 |
D/D |
9,391 |
2,195,469 |
0 |
- |
|
ALLO |
Allogene Therapeutics, In... |
President and CEO |
|
2019-09-05 |
4 |
A |
$0.00 |
$0 |
I/I |
9,402 |
1,154,302 |
0 |
- |
|
ALLO |
Allogene Therapeutics, In... |
President and CEO |
|
2019-09-23 |
4 |
A |
$0.00 |
$0 |
I/I |
9,402 |
1,163,704 |
0 |
- |
|
ALLO |
Allogene Therapeutics, In... |
President and CEO |
|
2019-09-23 |
4 |
A |
$0.00 |
$0 |
D/D |
9,391 |
2,205,963 |
0 |
- |
|
ALLO |
Allogene Therapeutics, In... |
President and CEO |
|
2019-10-25 |
4 |
A |
$0.00 |
$0 |
I/I |
9,402 |
1,173,106 |
0 |
- |
|
ALLO |
Allogene Therapeutics, In... |
President and CEO |
|
2019-10-25 |
4 |
A |
$0.00 |
$0 |
D/D |
9,391 |
2,215,354 |
0 |
- |
|
ALLO |
Allogene Therapeutics, In... |
President and CEO |
|
2020-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
9,391 |
2,234,136 |
0 |
- |
|
ALLO |
Allogene Therapeutics, In... |
President and CEO |
|
2020-03-04 |
4 |
A |
$0.00 |
$0 |
I/I |
9,402 |
1,191,910 |
0 |
- |
|
64 Records found
|
|
Page 2 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|